Explore By Subject Area   

Lead Editorial

How Voyager Therapeutics is Driving Receptor-Mediated CNS Delivery

How Voyager Therapeutics is Driving Receptor-Mediated CNS Delivery

Toby Ferguson, MD, PhD, CMO of Voyager Therapeutics, discusses his transition from Biogen to Voyager, biomarker-driven drug development and the company’s approach to receptor-mediated drug delivery approach.

Read More

More Related Content

Editorial

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.